Posted inMarket
Needham Lowers Ciena Stock Price Target Amid Margin Concerns
Financial firm Needham adjusts its price target for Ciena stock, citing growing pressures on profitability and future margin outlooks.
Posted inMarket
VersaBank Stock Price Target Lowered by Raymond James Following Earnings Miss
Raymond James adjusts VersaBank stock price target after a recent financial performance miss, prompting a careful reassessment among market analysts.
Posted inMarket
BTIG Raises Climb Bio Stock Price Target to $32 Following Phase 1 Data
BTIG has increased its price target for Climb Bio stock to $32 following promising phase 1 clinical trial data results.
Posted inMarket
Raymond James Lowers Dycom Industries Price Target Amid Guidance Worries
Discover why Raymond James reduced its stock price target for Dycom Industries following recent financial guidance updates and market concerns.
Posted inMarket
Baird Increases Climb Bio Stock Price Target Following Trial Data
Financial firm Baird has raised its price target for Climb Bio stock to $25 following recent clinical trial data updates.
Posted inMarket
Bernstein Reaffirms Outperform Rating on IREN Stock With $100 Price Target
Investment firm Bernstein maintains its Outperform rating on IREN stock, setting an ambitious price target of $100 amid evolving market dynamics.
